Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Learn how the proposed 2023 MPFS could impact your practice | Influential cardiologist dies at 88
Friday, August 12, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

How would the proposed 2023 MPFS impact your cardiology practice? Use this free tool to find out

The American College of Cardiology has developed a helpful calculator that allows cardiologists and practice managers to estimate just how much the proposed 2023 MPFS could impact their practice.

READ MORE >
medical billing_5.jpg
Share on Twitter Share on Facebook Share on Linkedin

How would the proposed 2023 MPFS impact your cardiology practice? Use this free tool to find out

Share on Twitter Share on Facebook Share on Linkedin
medical billing_5.jpg
The American College of Cardiology has developed a helpful calculator that allows cardiologists and practice managers to estimate just how much the proposed 2023 MPFS could impact their practice.
READ MORE >

Cardiovascular deaths are on the decline—but there is still a lot of work to do

Three recent NIH-supported studies took a close look at disparities in cardiovascular care.

READ MORE >
elderly patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular deaths are on the decline—but there is still a lot of work to do

Share on Twitter Share on Facebook Share on Linkedin
elderly patient and doctor
Three recent NIH-supported studies took a close look at disparities in cardiovascular care.
READ MORE >

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

READ MORE >
Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI
Share on Twitter Share on Facebook Share on Linkedin

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

Share on Twitter Share on Facebook Share on Linkedin
Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI
“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.
READ MORE >

Featured Articles

Possible carcinogen detected in multiple type 2 diabetes medications

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

READ MORE >
Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes
Share on Twitter Share on Facebook Share on Linkedin

Possible carcinogen detected in multiple type 2 diabetes medications

Share on Twitter Share on Facebook Share on Linkedin
Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes
To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 
READ MORE >

AI's impact on cardiology continues to grow, leading to $1.6B in business deals in 2021 alone

A new report by data analysts highlights a trend many in cardiology have already noticed: the continued prominence of AI-powered solutions designed to diagnose and treat CVD. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI's impact on cardiology continues to grow, leading to $1.6B in business deals in 2021 alone

Share on Twitter Share on Facebook Share on Linkedin
A new report by data analysts highlights a trend many in cardiology have already noticed: the continued prominence of AI-powered solutions designed to diagnose and treat CVD. 
READ MORE >

‘Virtual wards’ could boost outcomes, save up to $10K per heart failure patient

Following medical discharge, a program consisting of at-home visits, telehealth appointments and clinic visits resulted in better outcomes and lower healthcare costs than typical post-discharge care.

READ MORE >
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Share on Twitter Share on Facebook Share on Linkedin

‘Virtual wards’ could boost outcomes, save up to $10K per heart failure patient

Share on Twitter Share on Facebook Share on Linkedin
A patient has a telehealth visit with their doctor remotely in their home via video conferencing. The COVID-19 cause massive movement to telehealth since 2020.
Following medical discharge, a program consisting of at-home visits, telehealth appointments and clinic visits resulted in better outcomes and lower healthcare costs than typical post-discharge care.
READ MORE >

In Case You Missed It

VIDEO: The role of cardiac CT in the 2021 chest pain guidelines

Ron Blankstein, MD, associate director of the cardiovascular imaging program and director of the cardiac computed tomography program for Brigham and Women's Hospital, was a co-author on the ACC 2021 Chest Pain Guidelines, which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for frontline imaging. 

READ MORE >
Ron Blankstein, MD, MSCCT, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women's Hospital, and professor of medicine, Harvard Medical School, was a co-author on the ACC 2021 Chest Pain Guidelines,[1] which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for front line imaging. He gave an overview of the guidelines during the 2022 Society of Cardiovascular CT (SCCT) meeting in July. #SCCT2022
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: The role of cardiac CT in the 2021 chest pain guidelines

Share on Twitter Share on Facebook Share on Linkedin
Ron Blankstein, MD, MSCCT, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women's Hospital, and professor of medicine, Harvard Medical School, was a co-author on the ACC 2021 Chest Pain Guidelines,[1] which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for front line imaging. He gave an overview of the guidelines during the 2022 Society of Cardiovascular CT (SCCT) meeting in July. #SCCT2022
Ron Blankstein, MD, associate director of the cardiovascular imaging program and director of the cardiac computed tomography program for Brigham and Women's Hospital, was a co-author on the ACC 2021 Chest Pain Guidelines, which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for frontline imaging. 
READ MORE >

In Other News

Physician group asks for extension on surprise billing regulations

While MGMA recognized that the No Surprises Act “established critical patient protections against balance billing and created new cost transparency tools to help patients,” the association argued the new requirements for 2022 also carried “ significant additional administrative burdens for group practices.”

READ MORE >
medical billing_5.jpg
Share on Twitter Share on Facebook Share on Linkedin

Physician group asks for extension on surprise billing regulations

Share on Twitter Share on Facebook Share on Linkedin
medical billing_5.jpg
While MGMA recognized that the No Surprises Act “established critical patient protections against balance billing and created new cost transparency tools to help patients,” the association argued the new requirements for 2022 also carried “ significant additional administrative burdens for group practices.”
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme